Neurovascular Devices or Interventional Neurology Market Size

InsightAce Analytics Sp. Ltd. announces the publication of a market assessment report on the “Global Neurovascular Devices or Interventional Neurology Market” – By-products (Aneurysm Coiling and Embolization Devices (Embolization Coils, Flow Diversion Devices, Liquid Embolism Agents), Cerebral Balloon Angioplasty and Stenting Systems ( carotid coils Arterial stents, embolic protectors, balloon catheters), support devices (microcatheters and guidewires) and neurothrombectomy devices (clot recovery, suction and aspiration, snares)), end users (hospitals and surgery centers, ambulatory care centers and research laboratories and academia) Institutes), Trends, Industry competition analysis, Revenues and forecast until 2031.

Request for sample pages: https://www.insightaceanalytic.com/request-sample/1345

According to the latest research from InsightAce Analytic, the global neurovascular devices or interventional neurology market will be valued at $2.66 billion in 2021. It is expected to reach USD 5.72 billion by 2031, at a CAGR of 9.13% during the forecast period of 2023-2031.

Coils, stents, clot removal devices, and other devices for the treatment of neurovascular diseases, such as cerebral aneurysms and neurovascular thrombectomy, fall into the categories of “neurovascular devices” or “interventional neurological devices.” Blood clots in the arteries and veins of the brain, which can also cause a stroke, are removed using clot removal, suction and aspiration equipment. Disorders of the arteries that supply oxygen-rich blood to the brain area are treated with neurovascular devices.

Increased demand for minimally invasive neurosurgical procedures, increase in the number of neurosurgical surgeries, adequate drug reimbursement for the treatment of neurovascular diseases, and rising government spending on healthcare facilities are the major factors driving the global neurovascular devices or interventional neurology market. The demand for neurovascular devices or interventional neurology is expected to be driven by increasing rates of stroke, cerebral aneurysms, epilepsy, arteriovenous malformations (AVMs), and carotid stenosis. However, over the next few years, market expansion is expected to be limited by patient ignorance about neurovascular problems and their treatments and the high price of neurovascular devices and surgical procedures.

North America is expected to be a major supplier of neurovascular devices and interventional neurology. This may be related to improved health care infrastructure, increased incidence of neurological disorders and chronic diseases, and improved health care infrastructure. Additionally, the neurovascular devices or interventional neurology market in the Asia-Pacific region is expected to witness significant growth. The neurovascular or interventional neurology device market is expected to grow due to the increasing number of patients with chronic neurological diseases and the introduction and approval of embolization devices in many countries.

Order this premium report: https://www.insightaceanalytic.com/buy-report/1345

Major market players operating in the neurovascular devices and interventional neurology market include:
Johnson & Johnson (USA), Medtronic PLC (Ireland), Stryker Corporation (USA), Terumo Corporation (Japan), Penumbra, Inc. (USA), Microport Scientific Corporation (China), Kaneka Corp. (Japan), Integer Holdings Corporation (USA), Balt (France), Perflow Medical (Israel), Phenox GmbH (Germany), Sensome (France), Evasc (Canada), Rapid Medical (Israel), Asahi Intecc Co. Ltd (Japan), Acandis GmbH (Germany), Medikit Co. Ltd (Japan), Imperative Care (USA), Lepu Medical (China), Cerus Endovascular (USA), MicroVention, Inc. (USA), Mizuho Medical (Japan), Peter Lazic GmBH (Germany), Spartan Micro (USA), Emboflu (Switzerland), Straub Medical AG (Switzerland), AngioDynamics (USA), Microbot Medical Inc. (USA) and others.

Recent collaborations and agreements on the market:
• As announced by Integer Holdings Corporation, in April 2022, Connemara Biomedical Holdings Teoranta, which includes its operating companies Aran Biomedical and Proxy Biomedical, was acquired. Integer’s ability to provide end-to-end solutions for demanding delivery and treatment devices in rapidly evolving cardiovascular fields such as structural heart, neurovascular, peripheral and endovascular, as well as general surgery, is now even greater thanks to the partnership with Aran company.
• In December 2021, the world’s leading medical technology provider, Stryker, and Microbot Medical Inc. (USA) started cooperation. To create the first neurovascular-specific robotic kits, Microbot Medical will work with Stryker’s neurovascular division to integrate its neurovascular instruments with Microbot’s LIBERTY robotic system.

Are you curious about the latest version of the report? Get report details @ https://www.insightaceanalytic.com/enquiry-before-buying/1345

Market segments
Global Neurovascular Devices or Interventional Neurology Market by Product, 2023-2031 ($Mn Value)
• Aneurysm coiling and embolization devices
o Embolism coils
o Bare detachable coils
o Coated detachable coils
o Flow reversing devices
o Liquid embolic agents
• Cerebral balloon angioplasty and stent systems
o Carotid stents
o Anti-embolism devices
o Balloon catheters
• Auxiliaries
o Microcatheters
o Guides
• Neurothrombectomy devices
o Clot collection
o Suction and aspiration devices
o Snare

Global Neurovascular Devices or Interventional Neurology Market by End User, 2023-2031 ($Mn Value)
• Hospitals and surgery centers
• Ambulatory care centers
• Research laboratories and academic institutes

Global Neurovascular Devices or Interventional Neurology Market by Region, 2023-2031 ($Mn Value)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

North America Neurovascular Devices or Interventional Neurology Market, by Country, 2023-2031 ($Mn Value)
• US
• Canada

European Neurovascular Devices or Interventional Neurology Market by Country, 2023-2031 ($Mn Value)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Neurovascular Devices or Interventional Neurology Market, by Country, 2023-2031 ($Mn Value)
• India
• China
• Japan
• South Korea
• Australia and New Zealand

Latin America Neurovascular Devices or Interventional Neurology Market, by Country, 2023-2031 ($Mn Value)
• Brazil
• Mexico
• Rest of Latin America

Middle East and Africa Neurovascular Devices or Interventional Neurology Market, by Country, 2023-2031 (USD Million Value)
• GCC countries
• South Africa
• Rest of the Middle East and Africa

Why you should buy this report:
 To obtain a comprehensive analysis of the prospects for the global neurovascular devices or interventional neurology market
 To obtain an industry overview and future trends in the neurovascular devices or interventional neurology market
 To analyze the factors influencing the Neurovascular Devices or Interventional Neurology market and challenges
 To get information about the forecast market value of neurovascular devices or interventional neurology (USD Million) for 2030
 Significant investments, mergers and acquisitions in the neurovascular device or interventional neurology industry

For more information @ https://www.insightaceanalytic.com/customisation/1345

[email protected]
InsightAce Analytics Sp. Sp. z o. o
Visit: www.insightaceanalytic.com
Tel: +1 551 226 6109
Asia: +91 79 72967118
Follow us on LinkedIn @ bit.ly/2tBXsgS
Follow us on Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA

InsightAce Analytic is a market research and consulting company that empowers clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to grow businesses. We help clients gain competitive advantage by identifying untapped markets, discovering new and competitive technologies, segmenting potential markets and repositioning products. Our specialty is delivering syndicated and custom market intelligence reports with in-depth analysis containing key market insights in a timely and cost-effective manner.

This release was published on openPR.